|
2025 |
Cytomegalovirus DNA Doubling Time for Early Identification of Clinically Significant Infection Episodes in Allogeneic Hematopoietic Stem Cell Transplant Recipients Undergoing Primary Letermovir Prophylaxis: A Multicenter Study.
|
Giménez E |
Giménez E, Cadenas IG, Piñana JL, Albert E, Vázquez L, Avendaño A, Cabrero M, Esquirol A, Martino R, López-Jiménez J, Cuesta MÁ, Humala K, Villar S, Rovira M, Heras I, Zudaire T, Arroyo I, Zabalza A, Aguado B, Solano C, Navarro D; Spanish Group for Hematopoietic Transplantation (GETH). |
Transpl Infect Dis. 2025 Jul 17:e70080. doi: 10.1111/tid.70080. Epub ahead of print. PMID: 40674366. |
2.6 |
Ver artículo
|
|
2025 |
Frequency and Distribution of KIR Genotypes of Donors-Recipient Pairs in the Haploidentical Haematopoietic Stem Cell Transplantation Setting: Collaborative Study by the Spanish Working Group in Histocompatibility and Transplant Immunology (GETHIT) and the Spanish Haematopoietic Transplantation and Cell Therapy Group (GETH-TC)
|
Luis-Hidalgo M |
Luis-Hidalgo M, Planelles D, Piñana JL, Carbonell J, Amat P, Gómez-Seguí I, Guerreiro M, Caballero A, Torío A, Pascual-Cascón MJ, Boix F, Marín Rubio L, Vázquez L, Martínez-Pomar N, Cunill V, Sampol A, Ochoa J, Arbona C, Solano C. |
HLA |
4.1 |
Ver artículo
|
|
2025 |
Thiotepa, busulfan and fludarabine conditioning regimen for adult patients with lymphoid malignancies undergoing allogeneic stem cell transplantation: a study on behalf of GETH-TC
|
M. Peña |
D. F. Martinez, A. Paviglianiti, A. Balaguer, J. Sanz, M. J. Pascual, B. Herruzo, C. Solano, A. Benzaquén, M. Q. Salas, M. Rovira, A. Nieto, I. Español, M. Huguet, L. Bento, A. J. Saéz & A. Mussetti |
Bone Marrow Transplantation |
4.5 |
Ver artículo
|
|
2025 |
Siltuximab for the treatment of early complications after chimeric antigen receptor T-cell therapy for acute lymphoblastic leukemia in children, adolescents, and young adults
|
Víctor Galán-Gómez |
Berta González-Martínez, Anna Alonso-Saladrigues, Susana Rives, Blanca Herrero, Mi Kwon, Jose Sánchez-Pina, Jordi Minguillón, Isabel Martínez-Romera, Isabel Mirones Aguilar, Carmen Mestre-Durán, Gema Casado, María Sánchez-Martín, Carlos Echecopar, Carlos González-Pérez, Odelaisy León-Triana, Cristina Aguirre-Portolés, Águeda Molinos-Quintana, Pere Barba, Pascual Balsalobre & Antonio Pérez-Martínez |
Experimental Hematology & Oncology |
9.4 |
Ver artículo
|
|
2025 |
Autologous Stem Cell Transplantation for Relapsed/Refractory Large B Cell Lymphoma: Multicenter GETH-TC/GETH Study
|
Leyre Bento |
Antonio Gutiérrez, Carmen Martinez, María Consejo Ortí Verdet, Marina Sorribes Portella, Ana Carolina Caballero Gonzalez, Marta Peña, Ariadna Pérez, Ana Jiménez-Ubieto, Lucía Medina, Mariana Beatriz Bastos Oreiro, Paula Fernández Caldas-González, Maria Belen Navarro, Isabel Salcedo, Pau Abrisqueta, Ignacio Español, Javier Cornago Navascués, Fernando Martin-Moro, Lucía García Tomás, Pilar Gómez-Prieto, María Rosario Varela, María Puente, Joud Zanabili, Teresa Zudaire, Izaskun Zeberio, Raquel del Campo, Leslie González Pinedo, Pedro Antonio Gonzalez-Sierra, Cristina Blázquez-Goñi, Jordina Rovira, Marta Sitges, Mireia Franch-Sarto, Almudena Cabero Martínez, Alberto Mussetti, Juan Montoro, Antonia Sampol, Anna Sureda, Dolores Caballero-Barrigon, Alejandro Martin Martin Garcia-Sancho |
Blood Advances |
7.4 |
Ver artículo
|
|
2025 |
Allo-HCT refined ELN 2022 risk classification: validation of the Adverse-Plus risk group in AML patients undergoing allogeneic hematopoietic cell transplantation within the Spanish Group for Hematopoietic Cell Transplantation (GETH-TC)
|
Carlos Jiménez-Vicente |
Jordi Esteve, Mónica Baile-González, Estefanía Pérez-López, Carmen Martin Calvo, Clara Aparicio, Itziar Oiartzabal Ormategi, Albert Esquirol, Felipe Peña-Muñoz, Sara Fernández-Luis, Inmaculada Heras Fernando, Ana Pilar González-Rodríguez, Alberto López-García, Jose Luis López-Lorenzo, Tamara Torrado, Adolfo Jesús Sáez Marín, Cynthia Acosta Fleytas, Lucía García, Sara Villar, Silvia Filaferro, Pascual Balsalobre, María Jesús Pascual Cascón & María Queralt Salas |
Blood Cancer Journal |
12.9 |
Ver artículo
|
|
2025 |
Chimeric antigen receptor T-cell therapy outcomes in T cell/histiocyte-rich large B-cell lymphoma and subsequent treatment strategies after disease progression: A GETH/GETH study
|
Mariana Bastos-Oreiro |
Gloria Iacoboni, Víctor N. Garcés, Ana C. Caballero, Nuria Martínez, Javier Delgado, Aitana Balaguer, Mi Kwon, Sonia Gonzalez de Villambrosia, Rafael Hernani, Ana Jimenez-Ubieto, Rebeca Bailen, Izaskun Zaberio, Alejandro Martín García-Sancho, Pere Barba |
HemaSphere |
11.9 |
Ver artículo
|
|
2025 |
Frailty assessment in adults undergoing allogeneic hematopoietic cell transplantation: insights from a multicenter GETH-TC study to optimize outcomes and care
|
Salas MQ |
Salas MQ, Solano MT, Baile Gonzalez M, Acera Gomez M, Fox L, Perez Artigas MM, Santamaría A, Quintela Gonzalez MC, Sanchez Salinas A, Salmeron Camacho JM, Illana Alvaro V, Abdallahi-Lefdil Z, Cornago Navascues J, Pardo L, Fernandez-Luis S, Vega Suarez LP, Villar S, Beorlegui-Murillo P, Esquirol A, Izquierdo Garcia I, Rodriguez Gonzalez S, Mussetti A, Lavilla E, Lopez-Marin J, Filaferro S, Cedillo A, Bento L and Sureda A |
Front. Immunol. 15:1512154. doi: 10.3389/fimmu.2024.1512154 |
5.7 |
Ver artículo
|
|
2024 |
Ruxolitinib in acute and chronic graft-versus-host disease: real life long-term experience in a multi-center study for adult and pediatric patients, on behalf of the GETH-TC.
|
Escamilla-Gómez V |
Escamilla-Gómez V, García Gutiérrez V, Alcalde-Mellado P, Astibia-Mahillo B, Chinea-Rodriguez A, López-Corral L, Acera-Gómez M, Torres Ochando MK, Borrero Borrego A, González Pinedo L, Zudaire Ripa T, González Vicent M, Benzaquén A, Izquierdo Garcia I, Asensi Cantó P, Montoro J, Martín-Domínguez FM, Orti G, Valcárcel D, Benitez-Carabante MI, Diaz-de-Heredia C, Cañamero E, Ferrá C, García-Cadenas I, Redondo S, Sisinni L, Perez-Martínez A, Mussetti A, Garcia-Mañó L, Palomo-Moraleda MDP, González-Sierra PA, Jurado M, Perez-Simon JA |
Bone Marrow Transplant. 2024 Dec 11. doi: 10.1038/s41409-024-02483-0. Online ahead of print.PMID: 39663471 |
4.5 |
Ver artículo
|
|
2024 |
Post-transplant relapse in pediatric acute lymphoblastic leukemia in the era of CAR-T cell therapy. A multicenter analysis of Grupo Español de Trasplante Hematopoyetico y Terapia Celular (GETH-TC) Pediatric Committee
|
M González Vicent |
B Molina, M Panesso, D Bueno, A Pascual 5, S Vinagre, Y Mozo, J L Fuster, R Olivas, C Fuentes, M López, A Regueiro, P Palomo, C Díaz de Heredia |
Cytotherapy |
3.7 |
Ver artículo
|
|
2024 |
Successful allogeneic CD34(+) hematopoietic stem cell boost for prolonged cytopenias following CAR T-cell therapy in B-cell acute lymphoblastic leukemia. On behalf of the Spanish Group for Hematopoietic Transplantation and Cellular Therapy (GETH-TC)
|
Molinos-Quintana Á |
Molinos-Quintana Á, Martínez-Cibrian N, Alonso-Saladrigues A, Galán-Gómez V, Bailén R, Buendía-López S, Fuentes-Socorro C, Kwon M, González-Vincent M, Pérez de Soto C, González-Martínez B, Rives S, Pérez-Hurtado JM, Ortiz-Maldonado V, Pérez-Simón JA. |
Bone Marrow Transplant. 2024 Nov 17. doi: 10.1038/s41409-024-02473-2. Online ahead of print.PMID: 39551836 |
4.5 |
Ver artículo
|
|
2024 |
Targeting Hedgehog Signaling with Glasdegib in Patients with Refractory Sclerotic Chronic GVHD: A Report of Two Phase I/II Trials
|
Rodríguez-Arbolí E |
Rodríguez-Arbolí E, Lee CJ, Caballero-Velázquez T, Martínez C, García-Calderón C, Jiménez-León MR, Bermúdez-Rodríguez MA, López-Corral L, Triguero A, Onstad L, Horwitz ME, Sarantopoulos S, Lee SJ, Pérez-Simón JA |
Clin Cancer Res. 2023 Oct 13;29(20):4057-4067. doi: 10.1158/1078-0432.CCR-23-0666. PMID: 37698881. |
11.5 |
Ver artículo
|
|
2024 |
Use of Eltrombopag to Improve Thrombocytopenia and Tranfusion Requirement in Anti-CD19 CAR-T Cell-Treated Patients
|
Mingot-Castellano ME |
Mingot-Castellano ME, Reguera-Ortega JL, Zafra Torres D, Hernani R, Lopez-Godino O, Guerreiro M, Herrero B, López-Corral L, Luna A, Gonzalez-Pinedo L, Chinea-Rodriguez A, Africa-Martín A, Bailen R, Martinez-Cibrian N, Balsalobre P, Filaferro S, Alonso-Saladrigues A, Barba P, Perez-Martinez A, Calbacho M, Perez-Simón JA, Sánchez-Pina JM, On Behalf Of The Spanish Group Of Hematopoietic Transplant And Cell Therapy Geth-Tc |
J Clin Med. 2024 Aug 28;13(17):5117. doi: 10.3390/jcm13175117. PMID: 39274330; PMCID: PMC11396136 |
4.96 |
Ver artículo
|
|
2024 |
Cardiac events occurring after allogeneic hematopoietic cell transplantation with post-transplant cyclophosphamide. Study conducted on behalf of the GETH-TC.
|
Salas MQ |
Salas MQ, Cascos E, López-García A, Pérez-López E, Baile-González M, López-Corral L, Pascual Cascón MJ, Luque M, Esquirol A, Heras Fernando I, Oiartzabal Ormtegi I, Sáez Marín AJ, Peña-Muñóz F, Fernández-Luis S, Domínguez-García JJ, Villar Fernández S, Fernández de Sanmamed Girón M, González Pinedo L, González-Rodríguez AP, Torrado T, García L, Filaferro S, Cedillo Á, Basalobre P, Ortí G, Jurado Chacón M. |
Bone Marrow Transplant. 2024 Dec;59(12):1694-1703. doi: 10.1038/s41409-024-02414-z. Epub 2024 Sep 14.PMID: 39277653 |
4.5 |
Ver artículo
|
|
2024 |
Accurate donor and recipient selection and a short time to transplant offer excellent outcomes in upfront hematopoietic stem cell transplantation from matched unrelated donors for pediatric severe aplastic anemia and refractory cytopenia of childhood. A study of the Spanish Pediatric Group for Hematopoietic Cell Transplantation and Cell Therapy (GETH-TC)
|
Uria-Oficialdegui ML |
Uria-Oficialdegui ML, Quintero V, Benitez-Carabante MI, Bueno D, Trabazo M, Lopez-Duarte M, Alonso L, Panesso M, Murillo-Sanjuan L, Fuentes C, Gomez G, Gonzalez-Vicent M, Verdu J, Diaz-de-Heredia C |
Bone Marrow Transplant. 2024 Sep 3. doi: 10.1038/s41409-024-02406-z. Epub ahead of print. PMID: 39227649 |
4.5 |
Ver artículo
|
|
2024 |
Update on Cytomegalovirus Infection Management in Allogeneic Hematopoietic Stem Cell Transplant Recipients. A Consensus Document of the Spanish Group for Hematopoietic Transplantation and Cell Therapy (GETH-TC).
|
Piñana JL |
Piñana JL, Giménez E, Vázquez L, Marcos MÁ, Guerreiro M, Duarte R, Pérez A, de Miguel C, Espigado I, González-Vicent M, Suarez-Lledó M, García-Cadenas I, Martino R, Cedillo A, Rovira M, de la Cámara R, Navarro D, Solano C. |
MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES |
2 |
Ver artículo
|
|
2024 |
Cardiac Events after Allo-HCT in Patients with Acute Myeloid Leukemia. Study Conducted con Behalf of the GETH-TC.
|
Salas MQ |
Salas MQ, Cascos E, Lopez-Garcia A, Pérez López E, Baile M, Martín-Rodriguez C, Pascual-Cascón MJ, Luque Garrido M, Esquirol A, Heras I, Peña-Muñóz F, Oiartzabal Ormategi I, Sáez-Marín AJ, Fernández-Luis S, Dominguez-Garcia JJ, Villar S, Fernández de Sanmamed Girón M, González-Pinedo L, Garcia-Maño L, Gonzalez-Rodriguez AP, Torrado Chedas T, Filafferro S, Cedillo A, Ortí G, Jurado M |
Blood Adv. 2024 Aug 23:bloodadvances.2024013535. doi: 10.1182/bloodadvances.2024013535. Epub ahead of print. PMID: 39178345 |
7.4 |
Ver artículo
|
|
2024 |
Haploidentical versus Cord Blood Transplantation in Pediatric AML. A Retrospective Outcome Analysis on Behalf of the Pediatric Subcommittee of GETH (Grupo Español de Trasplante Hematopoyético)
|
Sisinni L |
Sisinni L, Monserrate GXA, Hurtado JMP, Panesso M, Molina B, Fuentes C, Fuster JL, Verdu-Amoros J, Regueiro A, Palomo P, Beléndez C, Pascual A, Badell I, Mozo Y, Bueno D, Pérez-Martínez A, Fernández JM, Vicent MG, de Heredia CD |
Transplant Cell Ther. 2024 Jul 25:S2666-6367(24)00544-X. doi: 10.1016/j.jtct.2024.07.013. Epub ahead of print. PMID: 39067788 |
3.6 |
Ver artículo
|
|
2024 |
Post-transplant cyclophosphamide compared to sirolimus/tacrolimus in reduced intensity conditioning transplants for patients with lymphoid malignancies.
|
Fox ML |
Fox ML, García-Cadenas I, Navarro V, Martínez AP, Kara M, Bazán IS, Ferra Coll C, Bailén R, Bento L, Parody R, Esquirol A, Ortí G, Mussetti A, Salamero O, Martino R, González AP, Barba P, Kwon M, Solano C, Bosch F, Valcárcel D; Spanish Hematopoietic Stem Cell Transplantation and Cell Therapy Group (GETH-TC). |
Bone Marrow Transplant. 2024 Jun 24. doi: 10.1038/s41409-024-02322-2. Epub ahead of print. PMID: 38914883 |
4.5 |
Ver artículo
|
|
2024 |
Anti-CD19 CAR-T Cell Therapy in Elderly Patients: Multicentric Real-World Experience from GETH-TC/GETH
|
Bailén R |
Bailén R, Iacoboni G, Delgado J, López-Corral L, Hernani-Morales R, Ortiz-Maldonado V, Guerreiro M, Caballero AC, Guerra-Domínguez ML, Sánchez-Pina JM, Peña M, Torrent A, Pérez-Martínez A, Bastos-Oreiro M, Reguera-Ortega JL, Martín A, Hernandez-Boluda JC, Martínez-Cibrián N, Sanz J, Briones J, Henriquez HL, Calbacho M, Mussetti A, Sancho JM, Barba P, Kwon M; GETH-TC (Spanish Group of Stem Cell Transplantation and Cell Therapy) and GETH (Spanish Group of Lymphoma and Autologous Stem Cell Transplantation). |
Transplant Cell Ther. 2024 Jul 26:S2666-6367(24)00485-8. doi: 10.1016/j.jtct.2024.06.022. Epub ahead of print. PMID: 39069076 |
3.6 |
Ver artículo
|
